ArticleCells2026

Targeting TGFBR1 with the Investigational Inhibitor TP-6379 Improves Hematopoiesis in Low-Risk MDS Ex Vivo.

Tiffany Razabdouski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.